Skip to main content
    S

    Sanara Medtech Inc (SMTI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $32.76
    +0.41 (+1.27%)

    Market Cap: $297.06M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Sanara Medtech Inc (SMTI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 11, 2026. Financial statements from company filings, amounts in US dollars.

    Sanara Medtech reported revenue of $103.12M for the fiscal year ended Dec 31, 2025, up 19.0% from the year before. That year, net income was -$37.57M with a net margin of -36.4%, operating cash flow was $6.79M and free cash flow was $2.16M. The quarter ended Sep 30, 2026 had revenue of $28.43M and net income of -$1.41M.

    Revenue and Margins

    The operating margin was 7.1% in the fiscal year ended Dec 2025, the highest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $5.51M, a compound annual rate of 38.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$103.12M+19.0%92.7%7.1%-36.4%
    Dec 2024$86.67M+33.4%90.6%1.5%-11.4%
    Dec 2023$64.99M+41.8%87.9%-6.5%-6.8%
    Dec 2022$45.84M+89.9%86.1%-27.3%-17.7%
    Dec 2021$24.14M+54.9%90.4%-30.6%-33.1%
    Dec 2020$15.59M+32.5%89.6%-32.3%-28.5%
    Dec 2019$11.77M+101.6%89.7%-23.3%-23.9%
    Dec 2018$5.84M-7.4%91.3%-8.6%-10.3%
    Dec 2017$6.30M+14.5%87.2%1.9%5.3%
    Dec 2016$5.51MN/A82.9%-4.9%-7.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$103.12M$86.67M$64.99M$45.84M$24.14M$15.59M$11.77M$5.84M$6.30M$5.51M
    Cost of revenue$7.52M$8.14M$7.85M$6.36M$2.31M$1.62M$1.21M$507.42K$806.04K$943.58K
    Gross profit$95.60M$78.53M$57.14M$39.48M$21.83M$13.97M$10.56M$5.33M$5.50M$4.56M
    Research and development$5.07M$2.83M$4.13M$3.37M$558.70K$40.19K$0$0$0$0
    Operating income$7.30M$1.26M-$4.22M-$12.52M-$7.38M-$5.03M-$2.74M-$501.86K$120.44K-$272.13K
    Net income-$37.57M-$9.91M-$4.44M-$8.09M-$7.99M-$4.45M-$2.81M-$600.57K$331.31K-$415.75K
    EBITDA$11.54M$6.39M-$534.99K-$10.15M-$6.78M-$4.73M-$2.61M-$408.02K$251.78K-$180.39K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$28.43M$28.14M$27.80M$27.52M$26.33M$25.80M$23.43M$26.31M$21.67M$20.16M$18.54M$17.69M
    Gross profit$26.33M$26.16M$25.87M$25.64M$24.46M$23.87M$21.60M$24.06M$19.68M$18.15M$16.65M$15.90M
    Operating income$736.00K$1.78M$2.65M$6.47M$2.94M$2.49M$825.53K$4.90M$778.54K-$2.88M-$1.53M-$226.00K
    Net income-$1.41M-$452.86K$458.60K-$1.61M-$30.41M-$2.02M-$3.53M-$1.70M-$2.88M-$3.53M-$1.80M-$262.44K
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $46.87M exceeded cash and equivalents by $30.29M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$72.94M$88.09M$73.87M$61.04M$36.40M$9.83M$11.12M$1.71M$2.22M$2.17M
    Current assets$33.54M$33.31M$19.01M$20.62M$24.61M$4.48M$8.86M$1.69M$2.04M$2.00M
    Cash and equivalents$16.58M$15.88M$5.15M$8.96M$18.65M$455.37K$6.61M$176.42K$463.19K$833.48K
    Total liabilities$67.01M$49.18M$29.28M$19.32M$6.24M$3.99M$4.72M$1.12M$2.12M$2.59M
    Short-term debt$353.23K$358.69K$580.36K$0$203.29K$125.59K$117.53K$10.47K$1.20M$3.77K
    Long-term debt$46.52M$31.90M$11.05M$0N/AN/A$1.50M$0$0$1.20M
    Shareholder equity$5.93M$39.40M$44.83M$41.72M$30.64M$6.15M$6.61M$586.80K$102.54K-$423.07K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$72.24M$69.15M$69.28M$72.94M$71.09M$98.77M$96.38M$88.09M$88.55M$73.38M$70.91M$73.87M
    Total liabilities$64.57M$61.21M$62.26M$67.01M$64.95M$63.38M$59.71M$49.18M$49.09M$31.98M$27.90M$29.28M
    Cash and equivalents$16.79M$15.42M$13.59M$16.58M$14.94M$16.96M$20.69M$15.88M$16.28M$6.15M$2.83M$5.15M
    Shareholder equity$7.67M$7.93M$7.03M$5.93M$6.14M$35.39M$36.67M$39.40M$39.78M$41.71M$43.29M$44.83M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 31.8% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$6.79M-$23.78K-$3.25M-$5.55M-$4.81M-$4.03M-$2.17M$277.14K-$139.86K$409.25K
    Capital expenditures$4.63M$205.85K$265.25K$147.01K$171.87K$544.37K$182.82K$8.48K$43.90K$3.03K
    Free cash flow$2.16M-$229.63K-$3.51M-$5.70M-$4.99M-$4.58M-$2.35M$268.66K-$183.76K$406.22K
    Dividends paidN/AN/AN/A$220.00K$200.00K$0$200.00K$223.11K$32.49K$46.15K
    Investing cash flow-$14.97M-$6.61M-$10.21M-$3.51M-$5.28M-$2.74M-$1.20M-$8.48K-$85.88K-$3.03K
    Financing cash flow$8.89M$17.37M$9.64M-$627.35K$28.30M$622.33K$9.80M$0-$144.55K$244.93K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$3.90M$2.04M-$2.47M$3.95M$2.18M$2.66M-$2.00M$932.05K$2.05M-$1.41M-$1.59M-$848.53K
    Capital expendituresN/A$5.28K$43.77K$82.16K$1.06M$1.76M$1.72M$72.17K$9.10K$58.76K$65.82K$54.28K
    Free cash flowN/A$2.03M-$2.51M$3.86M$1.12M$902.65K-$3.72M$859.88K$2.04M-$1.47M-$1.66M-$902.81K
    Last 12 quarters

    Frequently Asked Questions About SMTI

    What is Sanara Medtech's annual revenue?

    Sanara Medtech reported revenue of $103.12M for the fiscal year ended Dec 31, 2025.

    How fast is Sanara Medtech's revenue growing?

    Revenue was up 19.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 31.0%.

    Is Sanara Medtech profitable?

    No. Sanara Medtech reported net income of -$37.57M for the fiscal year ended Dec 31, 2025, with a net margin of -36.4%.

    How much free cash flow does SMTI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $6.79M minus capital expenditures of $4.63M produced free cash flow of $2.16M.

    How much debt does Sanara Medtech have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $46.52M, short-term debt of $353.23K and cash and equivalents of $16.58M.